An in-depth look to PHARMOSA BIOPHARM INC operating, investing, and financing activities

6875 free cash flow for Q1 24 is -64.88 M TWD. For 2023, 6875 free cash flow was -39.04 M TWD and operating cash flow was 42.42 M TWD.